Concepedia

Rituximab-induced serum sickness is more frequent in autoimmune diseases as compared to hematological malignancies: A French nationwide study

Guillaume Bayer, Marie‐Sara Agier, Bertrand Lioger, Marion Lepelley, M. Zénut, Mary-Christine Lanoue, F. Maillot, A.‐P. Jonville‐Béra

European Journal of Internal Medicine · 2019 · 53 citations · 30 references

DOIFull text

Open access

Concepts

References

30

Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis

Jonathan Edwards, L Szczepański, Jacek Szechiński et al. · New England Journal of Medicine · 2004 · 2.6K citations · Full text

, , +17

Efficacy and safety of rituximab in moderately‐to‐severely active systemic lupus erythematosus: The randomized, double‐blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial

Joan T. Merrill, C. Michael Neuwelt, Daniel J. Wallace et al. · Arthritis & Rheumatism · 2009 · 1.4K citations · Full text

, , +13

Middleton’s Allergy: Principles and Practice

David A. Dorward, Christopher G. Lucas, Keith Allen et al. · 2013 · 840 citations

, , +12

B cell depletion as a novel treatment for systemic lupus erythematosus: A phase I/II dose‐escalation trial of rituximab

R. John Looney, Jennifer H. Anolik, Debbie Campbell et al. · Arthritis & Rheumatism · 2004 · 777 citations

, , +16

Cytokine-Release Syndrome in Patients With B-Cell Chronic Lymphocytic Leukemia and High Lymphocyte Counts After Treatment With an Anti-CD20 Monoclonal Antibody (Rituximab, IDEC-C2B8)

U. Winkler, Mark A. Jensen, Oliver Manzke et al. · Blood · 1999 · 658 citations

, , +17